Women who eat more potatoes before pregnancy may have higher rates of gestational diabetes—the form that occurs during pregnancy—compared to women who consume fewer potatoes, suggests a National Institutes of Health (NIH) study.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Spotlight: NICHD Needs Your Input for the All of Us Research Program
NICHD needs your input for NIH’s All of Us program.
Selected NICHD Research Advances of 2015
Over the past year, NICHD contributed to numerous scientific advances and key initiatives.
HIV Transmission from Mother to Child: From Epidemic to Near Elimination
Children are most likely to get HIV from their mothers in one of three ways: in the womb, during birth, or from breastfeeding or breast milk. NICHD research has helped establish safe and effective ways to prevent this type of HIV transmission. Check out our infographic to learn more.
NIH invests $46 million in technologies to monitor placental health
The National Institutes of Health has announced $46 million in research awards for the Human Placenta Project, an initiative to revolutionize understanding of the placenta. The awards will fund technology development and testing to assess placental function throughout pregnancy, with the ultimate goal of improving pregnancy outcomes and lifelong health.
Exploring Population Dynamics
NICHD’s Population Dynamics Branch supports research on a range of topics, including the factors that make populations rise and fall, such as fertility and mortality. We checked in with branch chief Rebecca Clark to learn more about the branch’s work.
Environmental Influences on Child Health Outcomes
NIH seeks input on a proposed new research program to assess biological, chemical, psychosocial, and other environmental influences on child health outcomes. Join one of NIH’s webinars to learn more.
Q&A with Human Placenta Project Coordinator David Weinberg
In 2014, NICHD launched the Human Placenta Project (HPP), a new initiative to revolutionize our understanding of the human placenta and its role in health and disease.
NIH announces $41.5 million in funding for the Human Placenta Project
The National Institutes of Health has dedicated $41.5 million for an initiative to understand and monitor the development of the human placenta during pregnancy. The funding will support the development of new technologies to assess the health of the placenta as it grows and matures, with the ultimate goal of improving the health of mothers and children.
Study Reaffirms Safety of Anti-HIV Drugs During Pregnancy
The antiretroviral drugs used to keep HIV at bay are an unqualified success at preventing the spread of the virus from mother to child. The drugs are not only essential for maintaining the health of a pregnant woman with HIV, they have also nearly eliminated the transmission of HIV to her baby. Among U.S. women, the likelihood of a mother passing the virus on to her child is now less than 1%.
NICHD Hosts Upcoming Lecture on Fetal Individualized Medicine
The next NICHD Director’s Lecture at the NIH will feature Diana Bianchi, M.D., from Tufts University School of Medicine. Her talk, titled “Changing Paradigms: From Prenatal Genetic Diagnosis to Fetal Individualized Medicine,” will take place on January 21, 2015, 9:00–10:00 a.m., in Lipsett Amphitheater, at NIH’s Clinical Center in Bethesda, Md.
NIH-sponsored study identifies superior drug regimen for preventing mother-to-child HIV transmission
For HIV-infected women in good immune health, taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor and two more after giving birth, an international clinical trial has found.
NICHD Blogs about Safe Infant Sleep on Parents.com
Shavon Artis, Dr.P.H., M.P.H., coordinator of the NICHD-led Safe to Sleep® campaign, recently published a blog post on safe infant sleep environments for the Parents Magazine website.
August Wrap-Up: Promoting Safe and Healthy Pregnancies
This August, we focused on pregnancy—providing information, tips, and resources, plus a chance for members of the public to chat with experts over a Twitter #pregnancychat.
An Aspirin a Day for Preeclampsia Prevention
Aspirin is generally not recommended during pregnancy, as it can lead to bleeding problems for both mother and baby. But for some women, the benefits of a daily low-dose aspirin after the first trimester may outweigh the risk.
Healthy Pre-Pregnancy Diet and Exercise May Reduce Risk of Gestational Diabetes
A series of studies by an NICHD researcher suggests that women who maintain a healthy diet and exercise before they become pregnant are less likely to develop gestational diabetes mellitus, a type of diabetes that occurs only in pregnant women.
Healthy Pregnancies, Healthy Newborns: Research to Improve Outcomes
Ensuring the health and wellbeing of pregnant women and newborns is central to the NICHD mission. Scientists supported by our Pregnancy and Perinatology Branch (PPB) conduct research related to improving care for pregnant women and newborns, preventing preterm labor and birth and other birth complications, and treating diseases in newborns.
NICHD Podcasts Feature Research on Maternal Smoking
Many people are familiar with the health effects of cigarette smoking and secondhand smoke. Research has also tied smoking during pregnancy to later health and behavior problems in children. This podcast round-up features three interviews with NICHD grantees interested in the connections between maternal smoking and child health.
NIH Institutes Commit $2 Million to Small Businesses to Promote Placental Research
This month the NICHD and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) reissued two funding announcements, inviting grant applications for the development of methods to assess placental development and function. The Institutes intend to commit an estimated total of $2 million to small businesses in 2015 to support this research.
The NICHD Continues the Fight to Eliminate Prenatal and Infant Infections
This February marks the 20th anniversary of the results of Pediatric AIDS Clinical Trials Group Protocol 076—the first study to show that drug therapy could reduce the risk of mother-to-child transmission of HIV/AIDS. The NICHD and the National Institute of Allergy and Infectious Diseases (NIAID) co-funded this study.